Alex Dasalla | Head of Investor Relations |
Joe Ciaffoni | Chief Executive Officer |
Paul Brannelly | Chief Financial Officer |
Scott Dreyer | Chief Commercial Officer |
David Amsellem | Piper Jaffray |
Serge Belanger | Needham & Company |
David Steinberg | Jefferies |
Myles Minter | William Blair |
Brandon Folkes | Cantor Fitzgerald |
Kevin Kedra | Gabelli |
Good day, ladies and gentlemen, and welcome to Collegium Pharmaceuticals Third Quarter 2018 Earnings Conference Call. At this time, all lines are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] And as a reminder, this call is being recorded for replay purposes. I would now like to turn the conference over to Alex Dasalla, Head of Investor Relations.